A CT-Based Radiomics Approach to Predict Nivolumab Response in Advanced Non-Small-Cell Lung Cancer

PURPOSE: This study aims to develop a CT-based radiomics model to predict clinical outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with nivolumab. METHODS: Forty-six stage IIIB/IV NSCLC patients without EGFR mutation or ALK rearrangement who received nivolumab were enrolled....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Gong, Jing, Yu, Hui, Liu, Quan, Wang, Shengping, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943844/
https://www.ncbi.nlm.nih.gov/pubmed/33718125
http://dx.doi.org/10.3389/fonc.2021.544339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943844/
https://www.ncbi.nlm.nih.gov/pubmed/33718125
http://dx.doi.org/10.3389/fonc.2021.544339

Ejemplares similares